Miranda Brown

Statistics

Publications

Citations

H-Index

Active since

2024

Affiliations

University of Colorado Anschutz Medical Campus(Current)

Yale Cancer Center

Vall d'Hebron Hospital Universitari

Institut Gustave Roussy

Hospital de Sant Pau

Miranda Brown is an author at University of Colorado Anschutz Medical Campus specializing in immune checkpoint combination therapy, immunotherapy, and non-small cell lung cancer immunotherapy.

Publications per year

2024–2025

Publications

Durvalumab Alone or Combined With Novel Agents for Unresectable Stage III Non–Small Cell Lung Cancer

Charu Aggarwal, Alex Martínez‐Martí, Margarita Majem et al. · JAMA Network Open · 2025 · 19 citations · Full text

Medicine, Oncology, Pharmacology +17

Updated results from COAST, a phase 2 study of durvalumab (D) ± oleclumab (O) or monalizumab (M) in patients (pts) with stage III unresectable non-small cell lung cancer (uNSCLC).

Charu Aggarwal, Alex Martínez‐Martí, Margarita Majem et al. · Journal of Clinical Oncology · 2024 · 11 citations

Medicine, Immunology, Oncology +17

Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myeloma

Meletios Α. Dimopoulos, Magdalini Migkou, Manisha Bhutani et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2024 · 10 citations

Medicine, Pharmacokinetics, Pharmacology +16

1–3 of 3